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Abstract  
Background:  The impact of specialist weight management services (Tier 3) for children 
with severe and complex obesity in the UK is unclear. This review aims to examine the 
impact of child Tier 3 services in the UK, exploring service characteristics and implications 
for practice. 
Methods: Rapid systematic review of any study examining specialist weight management 
interventions in any UK setting including children (2-18 years) with a body mass index 
>99.6th centile or >98th centile with comorbidity.  
Results: Twelve studies (5 RCTs and 7 uncontrolled) were included in a variety of settings. 
Study quality was moderate or low and mean baseline body mass index z-score ranged from 
2.7 to 3.6 units. Study samples were small and children were predominantly older (10-14 
years), female and white. Multidisciplinary team composition and eligibility criteria varied; 
dropout ranged from 5% to 43%. Improvements in zBMIover 1-24 months ranged from -0.13 
to -0.41 units.  
Conclusions: Specialist weight management interventions for children with severe obesity 
demonstrated a reduction in zBMI, across a variety of UK settings. Studies were 
heterogeneous in content and thus conclusions on service design cannot be drawn. There is 
a paucity of evidence for Tier 3 services for children, and further research is required. 
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Introduction 
Overweight and obesity in children aged 2-18 years has increased throughout the world, 
presenting a global public health crisis1. In England there has been a rise in severe 
paediatric obesity prevalence; an estimated 2.9% of girls and 3.9% of boys aged 10–11 
years, have severe obesity (body mass index [BMI] ≥99.6th centile)2. The rise in severe 
paediatric obesity prevalence may result in a greater risk of adverse cardio-metabolic events 
and severe obesity in adulthood3.  Generally, socioeconomically disadvantaged children in 
high-income countries4-6 such as England are at greater risk of becoming obese. However, 
this relationship may vary by population demographics such as age, gender, and ethnicity7,8. 
 
In England, the obesity pathway includes; Tier 1: universal prevention services; Tier 2: 
lifestyle weight management services (WMS); Tier 3: specialist, multidisciplinary WMS; and 
Tier 4: bariatric surgery9. Recent National Institute for Health and Care Excellence (NICE)10 
quality standards state that ‘Children and young people who are overweight or obese and 
have significant comorbidities or complex needs are referred to a paediatrician with a special 
interest in obesity for investigations and access to Tier 3 services’11.  
 
Tier 3 WMS are defined as multicomponent, multidisciplinary and specialist services for 
children with severe obesity. A Tier 3 service usually comprises of a multidisciplinary team 
(MDT) of specialists, led by a clinician and typically including: a physician (consultant or GP 
with a special interest); specialist nurse; specialist dietitian; psychologist or psychiatrist; and 
physiotherapist/physical activity specialist/physiology9. Public Health England (PHE) 
provides a framework for evaluating WMS enabling standardised evaluation, which is 
applicable for Tier 3 services12. 
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Some clinical commissioning groups and local authorities i  commission Tier 3 services, 
although locally what defines a tier 3 service for children and young people varies.  There is 
no universal provision across England, with a number of areas not offering any or little in the 
way of specialist services9,13-15. There is a lack of evidence evaluating the effectiveness and 
cost-effectiveness of Tier 3 services for children and a lack of information describing the 
composition of and effectiveness of differing models of the specialist team.  
 
Previous research into the effectiveness of WMS for children has largely focused on lifestyle, 
multicomponent services, known as Tier 2, though these services are often for overweight 
children, and don’t necessarily meet the needs of children with severe or complex forms of 
obesity16. This review aims to establish the evidence base for Tier 3 WMS for children by 
exploring service characteristics, impact and implications for practice. This paper is 
published as a summary of a report commissioned by PHE. Importantly, part of the 
translational work associated with this review involved the development of toolkits to support 
commissioners and providers of obesity services, as outlined in The Department of Health’s 
letter detailing PHE’s Strategic Remit and Priorities17.  
 
Methods 
A protocol (a priori, unpublished) was developed in collaboration with a project steering 
group (for membership see Acknowledgements). The methods are underpinned by the 
Joanna Briggs Institute (JBI) methodology for scoping reviews18. The template for 
intervention description and replication (TIDieR) checklist and guide were used to extract 
data on delivery and context19. The review is reported following the Preferred Reporting 
Items for Systematic Reviews guidelines (PRISMA)20. It was a rapid review that was 
designed to be responsive to policy need and so a broad and flexible approach was taken. 
Pragmatic decisions were made regarding the methodology and inclusion criteria by the 
                                                          
i Clinical commissioning groups and local authorities are public bodies with a responsibility for providing clinical 
and public health services in England 
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project steering group and literature searches were limited to 2005 onwards to ensure 
studies were most relevant to current clinical practice. 
 
Inclusion criteria 
A preliminary scoping search identified very few published randomised controlled trials 
(RCTs) of Tier 3 WMS for children in the UK. As such, we took an overarching approach 
used by NICE to identify the best available evidence21. Thus studies of any design reporting 
outcomes pre and post-intervention were included. Studies with and without a comparator 
group were included without restriction on the type of comparator. 
 
Children aged 2-18 years with a mean baseline BMI >99.6th centile or >98th centile with 
comorbidities were included. We applied a mean baseline BMI rather than an individual cut-
off because we were aware of variability and inconsistency in eligibility. As many of the 
studies identified would pre-date the concept and definition of a Tier 3 service, a pragmatic 
decision was taken to include WMS that, although not Tier 3, were specialist multicomponent 
multidisciplinary services for children that met mean baseline BMI criteria.  In addition, if a 
study reported outcomes for a subgroup that met our mean baseline BMI criteria, although 
the whole study did not, then the data for the relevant subgroup were extracted.  
 
Multicomponent interventions which included components of diet, physical activity and 
behaviour change were included. The intervention could also include pharmacotherapy for 
obesity although pharmacotherapy only interventions were excluded. Interventions delivered 
by a MDT including specialists or clinicians were included. All study designs which reported 
weight change data of any duration and in any setting were included. Interventions based in 
the UK and published from 2005 onwards were included.  
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Embase, MEDLINE and PsycINFO were searched from January 2005 to March 2016 and 
articles were retained within a Reference Manager database and further limited to UK-based 
studies using keywords and text words in the abstracts containing ‘England’, ‘Ireland’, 
‘Scotland’, ‘United Kingdom’ or ‘Wales’.  
 
Database searches were supplemented by grey literature searching, including hand 
searches and resources provided by the steering group and study author contacts. 
Reference lists of full-text articles were also searched for additional studies. The titles and 
abstracts were screened by one reviewer (TB) who then screened full-text articles. Articles 
that were unclear for inclusion were independently screened by a second reviewer (LE) and 
a steering group member (AA). Articles that remained unclear were referred to PHE for 
advice (JB, VC, BH).  
 
Data extraction tables were developed to record participant and study characteristics, 
intervention components and outcomes. Quality appraisals were carried out using the JBI 
appraisal tools22. The studies were subjectively ranked as low (<4/9), moderate (4-6/9) or 
high quality (≥7/9), the full appraisal results for each study can be found in Table S4. All data 
were independently extracted by two reviewers (TB, COM); a third reviewer (LE) was 
consulted if any queries arose. Evidence was appraised taking account of study design, 
quality and setting.   
 
Results 
Due to study heterogeneity, meta-analyses were not possible, therefore a narrative 
synthesis is provided. 
 
The searches identified 1913 articles of which 120 were obtained and screened as full-text 
articles. Figure 1 shows the study flow. Grey literature searching, reference list searching 
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and contacting authors resulted in the identification of an additional two studies23,24. In total, 
12 studies23-34 met the inclusion criteria and were included; 1 study is ongoing35 and 109 
articles were excluded, of which 15 related to adults and are reported in a separate 
systematic review36. Table 1 shows study characteristics including participant baseline 
characteristics. See supporting information for detailed information on the characteristics of 
included studies (Table S1), descriptions of interventions (Table S2), MDT composition 
(Table S3) quality assessment (Table S4) and outcomes (Table S5). 
 
Characteristics of the interventions 
Study design 
Five studies were RCTs and seven were observational studies without a comparison group. 
The comparator groups in the RCTs were either another active intervention or standard care.  
Setting 
Six studies (2 RCTs and 4 uncontrolled) evaluated Tier 3 WMS, three of which were based  
in an established Bristol service and three were NHS funded service pilots (one hospital and 
two community-based). Six further studies (3 RCTs and 3 uncontrolled) had similar 
characteristics to a Tier 3 service and were based in various community settings including 
four studies at the same residential camp in Leeds.  
 
Content  
All interventions were multicomponent and included diet, exercise and behaviour change; no 
studies included referral to or from bariatric surgery or the use of anti-obesity 
pharmacotherapy. All of the studies required some form of parental engagement with the 
intervention. Some studies reported a theoretical underpinning of the intervention and 
training of programme deliverers. There was no evidence identified regarding user group 
involvement in the design of the services. The studies were heterogeneous making 
comparisons of service characteristics difficult. 
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Delivery 
The MDT composition varied across the studies and members included a physician 
(consultant or GP with a special interest), specialist dietitian, specialist nurse, psychologist or 
psychiatrist, physiotherapist or physical activity specialist or physiologist. Five studies 
reported the involvement of a physician as part of the MDT. Seven studies included a 
dietitian, of which two were paediatric dietitians. Three studies included a nurse. Two studies 
included a psychologist or psychiatrist; five studies included a physiotherapist or physical 
activity specialist or physiologist. It was not always clear if these members were specialists 
in obesity management. All four studies based in secondary care had physician involvement 
whereas only one community based study had physician involvement. The four residential 
camp studies lacked details about programme delivery (Table S3). 
 
Size and duration 
Studies included relatively small samples ranging from 7 to 106 participants.  Duration of the 
four camp based interventions ranged from 27 days to 7 weeks. Duration of the other eight 
studies ranged from 6 to 24 months with only four studies reporting follow up at 12 months or 
longer. Three studies followed-up participants after a period without active intervention and 
evaluated the sustainability of weight loss. Only two studies assessed all participants at 
follow up. Table S2 provides detailed description of interventions. 
 
Quality 
None of the studies were rated as high quality, the majority were of moderate quality, and a 
small number low quality. The quality domains that most studies failed to meet were 
insufficient duration of follow-up and exclusion of dropouts from the analyses. Most of the 
RCTs lacked blinding and comparability of groups at baseline. None of the uncontrolled 
studies were based on random samples and all of them lacked discussion of potential 
confounding factors.  
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Participants 
All studies reported a mean baseline weight which facilitated their eligibility to be included in 
this review. BMI was reported in seven studies and ranged from 27 to 35 kg/m2; mean 
baseline zBMIii was reported in ten studies and ranged from 2.7 to 3.6. The mean baseline 
BMI/zBMI was consistently higher than the minimum required to meet the eligibility criteria in 
each individual study. 
 
Within the individual studies, eligibility criteria for weight varied widely, both in terms of 
criteria used and cut-off applied. In studies using centile data, cut-offs ranged from the 85th 
centile to the 98th centile. In four studies, eligibility criteria for weight were not explicit.  Two 
studies reported excluding children with Type 2 Diabetes at baseline24,27. One study 
excluded children with underlying medical problems such as hypothyroidism and medication 
for insulin resistance28. One study included children with complex health and/or social needs 
but did not further define this30. In general the other studies appeared to adopt relatively wide 
inclusion criteria; two studies25,33 reported that no exclusion criteria were used in addition to 
weight.  
 
Baseline age was reported in all studies and ranged from 10 to 14 years. All studies included 
boys and girls; the majority were girls (54% to 75%). Four studies reported ethnicity, the 
majority in each sample were ‘white’ (59% to 92%). Five studies reported socioeconomic 
status (SES), including employment status24,27 education level24 parental marital status24,25,30 
and deprivation scores33.  
 
Effects of interventions 
                                                          
ii BMI adjusted for age and sex. 
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Table 2 provides zBMI data and Table S5 provides detailed information for all reported 
outcomes. The camp studies were different from the other studies in that they were all 
intensive short-term residential programmes away from parents; for this reason, we analysed 
effects for the camp studies separately. 
 
Attendance/compliance  
Non-residential studies 
Seven of eight studies reported dropout of 18%27 to 43%23. Only one study reported 
comparing the characteristics of dropouts with completers: dropouts had a higher mean 
baseline BMI28. Attendance rates varied between studies, only one study evaluated the 
effect of attendance on weight loss and reported no significant effect of attendance on 
weight loss27. 
 
Residential studies (camps).  
Two of four camp studies reported dropout of 5%26 and 10%29. 
 
Anthropometric  
All studies (apart from one camp study32 and one non-residential study30) reported change in 
mean zBMI. Seven studies demonstrated significant improvement in anthropometric 
measurements from baseline to follow-up. One study24 maintained baseline zBMI and one 
study showed a non-significant reduction in zBMI at 1.7 years. In studies with a comparison 
group (all comparison groups involved some form of active care); all comparison groups also 
reduced zBMI from baseline to follow-up. Change in zBMI from baseline to last follow-up 
ranged from -0.06 to -0.50 over a duration of six to 12 months. One study34 used self-
reported measures via on online survey and reported reduction of 0.50 zBMI.  
Three of the four camp studies26,29,31 reported change in zBMI over time which ranged from -
0.25 to -0.36 over a duration of 27 days to six weeks. Two of these camp studies26,29 were 
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RCTs comparing high protein diet (22.5% and 25%) with standard diet: there was no 
significant difference in change in zBMI between the groups (all groups reduced zBMI over 
time).  
There was no discernible pattern between length of the intervention and amount of reduction 
in zBMI. For example, similar reductions in zBMI were achieved in residential camps of 4-6 
weeks duration as in longer-term (six to 24 months) hospital or community-based 
interventions.   
Sustainability of zBMI improvements was only examined in a small number of studies. Sabin 
et al.33 reported a zBMI reduction at 1.7 years of -0.24 (95% confidence interval [CI]: −0.48 
to 1.43). A crossover study25 of a 12-month school-based family programme followed by 12 
months of body composition monitoring (and vice versa) demonstrated significant reduction 
in zBMI in the intervention/control group but not the control/intervention group at 12 months 
and 24 months, with the intervention/control group achieving -0.13 zBMI at 1 year and -0.41 
zBMI at two years (but adjusted mean difference between both groups at 12 and 24-month 
was not significantly different).  None of the camp studies reported on sustainability of 
improvements in outcomes. 
 
Sociodemographic factors as potential effect modifiers 
Two non-residential studies evaluated whether change in anthropometric outcomes varied 
by sociodemographic characteristics. The evidence was inconsistent. Sabin et al33 reported 
that age was the most important predictor, with younger children achieving larger reductions 
in zBMI. More boys than girls were likely to achieve target reductions in zBMI and those 
without a parental history of obesity were more likely to achieve greater reductions in zBMI. 
No significant correlation was seen between the Townsend deprivation score and fall in 
zBMI over one year. Edwards et al27 reported that loss of overweight during treatment was 
not related to age, gender or initial %BMI. 
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Two residential studies reported on potential effect modifiers. Kulendran et al32 reported that 
there was a greater reduction in BMI in boys (-3.17, standard deviation [sd] 0.89 kg/m2) than 
in girls (-2.62, sd 0.89 kg/m2), p=0.03. However, another camp study31 reported a mean 
weight change of -8.36 kg with a non-significant difference between boys and girls. 
 
Comorbidities  
Two non-residential hospital-based studies reported on clinical outcomes including blood 
pressure, insulin, leptin and lipids. One hospital-based study28 significantly improved high-
density lipoprotein cholesterol concentration (mean adjusted difference −0.07, 95% CI: −0.14 
to −0.00; p=0.043) when a computerised device to slow eating was compared with the 
standard care group at 12 months. However, there were no significant differences between 
the groups in low-density lipoprotein cholesterol concentration, high sensitivity C reactive 
protein, insulin resistance, or blood pressure (BP) at 12 months. However it should be noted 
that each arm did not receive exactly the same standard care. In another hospital-based 
study33 , ‘achievers’ (i.e. those who have reduced zBMI by at least 0.5 or obtained a BMI 
centile <99.6) had lower mean levels of insulin, leptin and Homeostasis Model Assessment 
of Insulin Resistance than the ‘non-achievers’ and ≤1 year dropouts, but none of the 
differences were statistically significant.  
 
Three residential camp studies reported on clinical outcomes. Two studies compared varying 
levels of protein in diets and showed significant improvement over time for diastolic but not 
systolic BP26 and for both diastolic and systolic BP29 for both high and standard protein diets: 
raising the level of daily dietary protein had no impact on these changes. There was also 
significant improvement in all blood lipids over time regardless of diet group29. Both of these 
studies were intensive and short-term. Another study reported significant improvement from 
baseline for diastolic BP32. 
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Quality of Life 
Three studies (all non-residential) reported on quality of life outcomes, two studies23,28 based 
at the children’s hospital in Bristol used the same measure (PedsQL version 4.0) and 
reported similar and positive improvements from baseline to 12-month follow-up for all 
groups. A community-based study showed improvements to a number of self-report aspects 
of quality of life30. Three studies reported reductions in depression following weight 
management interventions24,27,30. There was also significant improvement in self-concept 
and in self-perception relating to physical appearance24,27.  
 
Behaviour change  
Five studies (all non-residential) reported behaviour change outcomes related to diet and 
physical activity. Whilst some improvements were observed, a range of different outcome 
measures were used making it difficult to compare findings across the studies.  
 
Provider and user views/opinions/satisfaction 
Three studies (all non-residential) reported some form of evaluation of the weight 
management programmes. Banks et al23 reported primary care clinics scored slightly higher 
than the hospital-based clinics although all mean scores were equivalent to ratings from 
‘excellent’ to ‘good’. 
 
A study of a family-based obesity treatment at Great Ormond Street London reported that 
running the groups was a positive experience for the health professionals, and families were 
extremely enthusiastic about the programme27,37. The majority of parents (18/20) and 
children (16/18) were very pleased that they had attended the programme. Fourteen out of 
20 parents considered the written information to be very helpful, as did 9/18 children, the 
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remainder found it quite helpful. Fifteen parents found the individual feedback session very 
helpful and four quite helpful.  
 
A community based study of the OSCAR programme included a qualitative evaluation which 
involved both the OSCAR families and the OSCAR team members30.  Health professionals 
and participating families had positive attitudes towards the helpfulness of the family 
meetings though this contrasted with the more negative attitudes of at least one of the 
families. Both providers and users felt that the 12-week programme was too short. 
 
Costs 
None of the studies included a cost-effectiveness analysis.  
 
Discussion 
Main finding of this review 
We set out to assess the evidence of effectiveness of specialist (Tier 3) WMS interventions 
for children; however, the majority of evidence was derived from observational studies and 
none of the RCTs compared a WM intervention to doing nothing (true control). Whilst the 
results suggest that specialist weight management services can achieve reductions in zBMI 
across a variety of different settings, we appreciate that much of the evidence derives from 
uncontrolled studies which should be interpreted with caution. The absence of a comparison 
group makes it impossible to know what would have happened without the intervention. 
However, the zBMI reductions observed in the interventions arms of the RCTs fell within the 
range observed across all study designs.  
 
It was difficult to make further inferences about the impact of intervention characteristics on 
the specified outcomes, given the heterogeneity of the interventions and the study designs. 
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There was no discernible variation in zBMI by study quality, design or length of intervention. 
For example, similar reductions in zBMI were achieved in residential camps of 4-6 weeks 
duration, as those observed in longer-term (six to 24 months) hospital or community-based 
interventions.  As the camp studies were relatively intense interventions, this evidence might 
suggest that the intensity of the intervention rather than the duration, influences zBMI 
reduction. There was very limited evidence to suggest that reduction in zBMI can be 
maintained up to one year post-intervention. Given the chronic relapsing nature of obesity 
this requires further investigation. 
 
What is already known on this topic?  
A recently updated review38 examined RCTs of lifestyle treatments for obesity (not restricted 
to severe obesity and largely similar to Tier 2 services) in children aged 6 to 11 years. When 
the data from this review was sub-grouped by mean baseline BMI, the severe obesity 
intervention subgroup (defined as zBMI ≥2.67) had a change in zBMI over time ranging from 
+0.03 to -0.71. The mean difference between intervention and usual care control groups for 
this subgroup was not significant (-0.03, 95% CI: -0.10 to -0.02; p=0.46, n=8 trials, n=470 
participants). This demonstrates that the reduction in zBMI achieved in children in our 
review, which includes all types of study design, is within the range observed within RCTs; 
however, the RCT data did not show a significant difference between intervention and usual 
care groups. Another recent Cochrane review39 examining drug interventions for the 
treatment of childhood obesity, demonstrated an overall reduction in BMI of 1.3 kg/m2 in 
favour of drug interventions in children aged 10-14 years. This equates to a reduction of 0.28 
zBMI, which again falls within the range reported in this review, although no studies reported 
in this review included pharmacotherapy.  
 
The results for potential effect modifiers were inconsistent across the studies reported in this 
review. A recent review40 found limited evidence for the effectiveness of interventions with 
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the potential to reduce SES inequalities in obesity-related outcomes amongst children. 
Despite awareness that prevalence of obesity varies by ethnicity in the UK, only four studies 
in our review reported on ethnicity, and the majority of participants were white. A further 
systematic review41 of lifestyle interventions to prevent or treat obesity in South Asian 
children, meta-analysed a limited number of controlled trials, and found an unclear picture of 
the effects of interventions on BMI. Currently, we are unable to assess the equity impacts of 
WM interventions in the UK, this area consequently urgently requires further work. 
 
Since conducting the review, final outcomes for another Tier 3 service have been 
published42. SHINE (Self-Help, Independence, Nutrition and Exercise) is an established Tier 
3 service of psychosocial intervention for children and young people with severe obesity 
(BMI/waist circumference ≥99.6th centile, with or without comorbidities). The study is a 
retrospective evaluation of participants who attended the programme between 2011 and 
2016 (n = 435; age: 13.1 years, male: 51%, white: 87.4%, zBMI: 3.1 units). At 12-months 
there was a mean reduction in zBMI of 0.41 units (95% CI: 0.31–0.51, n=107 completers 
[31%]). This reduction in zBMI is at the upper end of the range of reductions observed in this 
review. 
 
What this study adds: 
This is the first systematic review of Tier 3 WMS for children in the UK, and highlights some 
important considerations for both practice and research.  
 
The majority of studies centred on children aged 10-14 years old. There appears to be a gap 
in the evidence for service provision for children under ten and young people over fourteen 
years. The eligibility criteria for Tier 3 services for children should be standardised and future 
services designed with user involvement (including family members and carers). The 
sustainability of zBMI reduction, is another key consideration, with a need for longer-term 
 17 
 
follow up data and further research on the most appropriate forms of post-intervention 
maintenance support.  This longer term research should include both cost and clinical 
effectiveness analyses.  
 
Future services and research should use the Public Health England standard evaluation 
frameworkiii and new minimum datasetiv, to collect comprehensive participant demographic 
data, to ensure service uptake and impact is equitable. This will also help facilitate 
necessary improvements in reporting service details, specifically who, when, what and how 
components are delivered, in order to evaluate these factors as potential effect modifiers. 
This would be supported by a greater clarity and adherence to, what constitutes a child tier 3 
weight management service, particularly regarding the composition of the MDT in terms of 
the minimum number of specialists, and definition of a specialist, including obesity specialist 
qualifications, experience and/or membership to specific bodies. In terms of outcome 
measures, whilst zBMI is a required outcome for any child weight management programme, 
clarification is required as to what constitutes a clinically meaningful reduction in zBMI in 
children. It is also important to consider, when delivering multi-component interventions, 
what it is the impact on wellbeing, and changes in co-morbidities, dietary and activity 
behaviours. These additional outcomes will help to determine any wider benefits, as well as 
improve understanding of how the intervention may be working.  
 
Limitations of this study 
It is important to note that due to available time and resource constraints only one person 
(TB) extracted and synthesised the data; thus lacking the rigor of double data extraction and 
synthesis as determined by Cochrane systematic reviews. It is also important to note that we 
included interventions that were not established Tier 3 services and would not meet the 
NICE CG189 guidance for Tier 3 services10. Including these studies enabled comparison of 
                                                          
iii http://webarchive.nationalarchives.gov.uk/20160805121933/http://www.noo.org.uk/pages.php5?pg=297 
iv https://www.gov.uk/government/publications/child-weight-management-services-collect-and-record-data 
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services across hospital, community and primary care sites; it also enabled evaluation of 
such services within select population groups. We took a pragmatic decision to include the 
residential camp-based studies despite scant details on the intervention, who delivered it 
and long term sustainability. These camp studies currently provide unique, intensive WMS; 
however in some UK areas, these residential interventions are regarded as a Tier 4 
provision. During screening it was often difficult to ascertain which of the community-based 
studies were Tier 3 and Tier 2 due to insufficient service delivery information. This highlights 
the lack of clarity in practice about the distinction between different service tiers. 
 
Despite a broad search for evidence from all study designs, the identified evidence was 
limited, not just in quality, but also in the fact that three studies were derived from the same 
hospital-based obesity clinic in Bristol, UK and four studies derived from the same residential 
camp in Leeds, UK. There is a complete lack of cost effectiveness data, and the clinical 
relevance of the findings remains unclear, with a lack of universal consensus as to what 
constitutes a clinically meaningful weight status change in children, despite several studies 
in the field,43,44,45. 
 
Conclusions 
There is a paucity of evidence, however the available literature suggests that Tier 3 WMS 
and other similar interventions for children with severe obesity (mean baseline BMI >99.6th 
centile or >98th centile with comorbidities) can demonstrate a reduction in zBMI which was 
achieved in a variety of settings and timeframes. It was not possible to discern the specific 
characteristics of an effective specialist weight management service for children with severe 
obesity. The clinical significance of improvements in zBMI requires clarification and 
consensus amongst policy-makers, health-care professionals and practitioners. This should 
be examined in high quality studies, that examine the sustainability of effect, and impact on 
wellbeing, diet and activity behaviours, co-morbidities and cost effectiveness. 
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Table 1 Summary of included study characteristics 
Author, year Study design Setting  Interventions Mean age, years 
(sd/95% CI) 
Mean baseline BMI  
z score (sd/95% CI) 
Female  
(%) 
*Banks 201223 Pilot RCT H Consultant led hospital clinic  11.5 (2.5) 3.17 (0.57) 58 
P Nurse-led  primary care clinic 11.4 (2.8) 2.86 (0.40) 64 
Coppins 201125 RCT crossover 
 
S Multicomponent family focused education followed 
by control (body composition monitoring) 
11.1 (NR) 2.7 (2.6 to 2.9)  
 
63 
Control (body composition monitoring) followed by 
multicomponent family focused education  
9.7 (NR) 2.8 (2.5 to 3.0) 70 
Duckworth 200926 RCT C High-protein (25%) + physical activity, reduced-
energy intake, and behaviour change, residential 
14.5 (1.8) 
 
3.03 (0.51) 
 
64 
Standard protein (15%) + physical activity, 
reduced-energy intake, and behaviour change, 
residential 
14.3 (1.9) 3.00 (0.72) 
**Edwards 200627 BA no control H Family based behavioural treatment for simple 
obesity 
10.6 (1.6) 3.23 (0.48) 70 
*Ford 201028 RCT H Mandometer (portable weighing scale that 
provides real time feedback during meals to slow 
down speed of eating and reduce total intake) + 
standard lifestyle modification 
12.7 (2.2) 3.29 (0.52) 56 
Standard lifestyle modification  12.5 (2.3) 3.21 (0.45) 56 
Gately 200729 RCT C High-protein (22.5%) + multi component 
residential behaviour change 
14.1 (2.0) 2.83 (0.42) 
 
59 
Standard protein (15%) + Multi component 
residential behaviour change 
14.4 (2.0) 3.10 (0.50) 69 
**Jinks 201330 Case study COM Family based multicomponent with a key worker 
and based on person-centred planning approach 
for children with obesity and complex health 
and/or social needs (not defined) 
8, 9, 10, 13 and 14 
(sd NR) 
NR  
BMI: 
Child A: 30.2 
Child B: 22.3 
Child D: 34.6 
Child E: 23.1 
Child F: 28.6 
40 
King 200731 BA no control C Residential programme of physical activity, 
reduced energy intake and behaviour change 
13.9 (1.6) 3.19 (0.52) 63 
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Author, year Study design Setting  Interventions Mean age, years 
(sd/95% CI) 
Mean baseline BMI  
z score (sd/95% CI) 
Female  
(%) 
Kulendran 201432 BA (non-obese 
control not 
analysed) 
C Residential programme of lifestyle and physical 
activity based on behaviour change 
14.3 (1.7) NR 
BMI: 33.75 (7.9) 
60 
**Murdoch 201124 Pilot BA no 
control 
COM Family based behavioural treatment (community-
based version of hospital-based intervention by 
Edwards 2006) 
10.5 (1.8) 3.16 (0.56) 53 
*Sabin 200733 BA no control H Paediatric obesity clinic 11.7 (2.2 to 17.8) 
 
3.6 (2.4 to 5.9) 54 
Stubbs 201234 Retrospective no 
control (web-
based 
questionnaire ) 
COM Commercial behaviour change weight 
management programme for young people  
13.4 (1.4) 
 
2.7 (0.7) 75 
Legend, Table 1: *established Tier 3 service; ** service pilots; BA: observational before-after study; BMI: body mass index; C: camp; CI: confidence interval; C/I: 
control/intervention; COM: community; F: female; H: hospital; I: intervention group; I/C: intervention/control; M: male; NR: not reported; P: primary care; RCT: randomised 
controlled trial; S; school; sd: standard deviation 
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Table 2 Body Mass Index (kg/m2) standard deviation score (zBMI) 
Intervention Body Mass Index (kg/m2) standard deviation score (zBMI) and 
standard deviation (sd)* 
Study ID Group  No. participants  Duration  
 
Mean change from baseline 
(sd/95% CI) 
 
Mean difference between 
groups (sd/95% CI) 
Banks 
201223 
consultant led hospital clinic  
 
Randomised:31  
Assessed: 23  
12 months -0.15 (–0.26 to –0.05)  
 
0.02 (-0.12 to 0.17) 
nurse-led  primary care clinic Randomised:45 
Assessed: 29 
-0.17 (–0.27 to –0.07) 
Coppins 
201125 
 
Family focused education  Randomised: 35 
Assessed: 35 
24 months 12 months (adjusted): 
-0.13 (95% CI: -0.26 to -0.008)  
24 months (adjusted): 
-0.41 (95% CI: -0.71 to -0.11)  
12 months (adjusted): 
-0.09 (-0.26 to 0.09), p=0.32 
24 months (adjusted): 
-0.3 (-0.62 to 0.02), p=0.06 
 
 
 
 
Control (body composition 
monitoring)  
Randomised: 30 
Assessed: 30 
12 months (adjusted): 
-0.14 (95% CI: 0.28 to -0.001) 
24 months (adjusted): 
0.16 (95% CI: -0.43 to 0.11) 
Edwards 
200627 
Family based behavioural 
treatment 
Referred: 37 
Entered: 33 
Assessed:27 
8-9 months -0.15, p<0.001 NA 
Ford 
201028 
 
Mandometer*** plus 
standard care 
 
Randomised: 54  
Assessed 12 months: 54 
Assessed 18 months: 44  
18 months 12 months:  
−0.36 (−0.27 to −0.46)  
 
12 months (adjusted):  
0.24 (0.11 to 0.36), p<0.001 
18-month (adjusted):  
0.27 (0.11 to 0.43), p=0.001 Standard care Randomised: 52 
Assessed 12 months: 52  
Assessed 18 months:43 
−0.14 (−0.05 to −0.22) 
 
Jinks 
201330 
Family based treatment Referred: 7 families 
Assessed: 5 families  
6 months NR, all but one of the referred 
children had reduced BMI on 
completion  
NA 
Murdoch 
201124 
Family based behavioural 
treatment 
Recruited: NR 
Assessed: 17 (completers) 
6 months -0.06, p=0.16 NA 
Sabin 
200733 
Paediatric obesity clinic Attended:137 
Assessed:112 (≥2 visits) 
19 months -0.24 (−0.48 to 1.43) NA 
Stubbs 
201234 
Commercial weight 
management programme  
Recruited: 96 
Assessed: 79 
6 months -0.5 (0.4), p<0.001 NA 
Camp studies 
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Legend, Table 2: *where BMI z score not reported we have reported BMI; ** Coppins 2011: children crossed over after 12 months therefore only first 12 month data analysed; 
*** Mandometer: (portable weighing scale that provides real time feedback during meals to slow down speed of eating and reduce total intake; C/I: control/intervention; CI: 
confidence interval; I/C: intervention/control; NA: not applicable; NR: not reported; NS: non-significant; SD: standard deviation 
 
Duckwort
h 200926 
High-protein (25%)  
 
Randomised: 100 (both 
groups) 
Assessed: 46  
31 days -0.25, p<0.001 NS between groups 
 Standard protein (15%) Randomised: 100 (both 
groups) 
Assessed: 49 
-0.25, p<0.001 
Gately 
200729 
High-protein (22.5%)  Randomised: 98 (both groups) 
Assessed: 41  
27 days -0.29, p<0.05; 
both groups combined: -0.27 (0.1), 
p<0.001 
NS between groups 
 Standard protein (15%) Randomised: 98 (both groups) 
Assessed: 39 
-0.26, p<0.05; 
both groups combined: -0.27 (0.1), 
p<0.001 
King 
200731 
Physical activity, reduced 
energy intake, behaviour 
change 
Volunteered: 38 
Assessed: 32 
6 weeks -0.36, (p value NR) NA 
Kulendran 
201432 
Lifestyle and physical activity 
and behaviour change 
Recruited: Unclear 
Assessed: 53 (completers) 
7 weeks NR, BMI: -2.83 kgm2 (0.29) reported 
as significant 
NA 
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Table and figure Legends 
Table 1: *established Tier 3 service; ** service pilots; BA: observational before-after study; 
BMI: body mass index; C: camp; CI: confidence interval; C/I: control/intervention; COM: 
community; F: female; H: hospital; I: intervention group; I/C: intervention/control; M: male; 
NR: not reported; P: primary care; RCT: randomised controlled trial; S; school; sd: standard 
deviation;  
 
Table 2: *where BMI z score not reported we have reported BMI; ** Coppins 2011: children 
crossed over after 12 months therefore only first 12 month data analysed; *** Mandometer: 
(portable weighing scale that provides real time feedback during meals to slow down speed 
of eating and reduce total intake; C/I: control/intervention; CI: confidence interval; I/C: 
intervention/control; NA: not applicable; NR: not reported; NS: non-significant; SD: standard 
deviation 
  
 
